Features

Group A

Placebo

Group B

Solifenacin

Group C

Tamsulosin

Group D

Tadalafil

No of Patients

29

32

31

29

Age

35.8

37.0

34.1

32

M:F

20:9

21:11

23:8

25:4

BMI (in kg/m²)

19.8

20.5

19.9

19

PCNL

9

8

7

7

URSL

20

24

24

22